Manufacturer record

Ridley Life Sciences Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Ridley Life Sciences Pvt. Ltd (Delhi) were declared Not of Standard Quality between December 2022 and October 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Ridley Life Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2022 to Oct 2023

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2022
3
Products affected
Assay
Most common failure
Oct 2023
Latest alert

Flagged batches per year

2022 · 12023 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Levetiracetam Oral Solution IP RL230004Mfg 2023-01 · Exp 2024-12 DescriptionDescription CDL KolkataCDSCO lab Oct 2023
Telmirid-40 (Telmisartan Tablets I.P. 40 mg) RT220651Mfg 2022-08 · Exp 2024-07 DissolutionDissolution CDTL KolkataCDSCO lab Mar 2023
Ridtas ? S (S(-)Amlodipine Tablets I.P.) RT220619Mfg 2022-08 · Exp 2024-07 Dissolution & AssayAssay CDL KolkataCDSCO lab Dec 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.